BREAKTHROUGHS BLOG

March 14, 2014

Research Roundup: What we’re reading this week

Senior Program Assistant
GHTC

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

More detailed information about the President’s fiscal year (FY) 2015 budget requests to Congress was released this week, resulting in a mixed bag for global health research and development. The Congressional Budget Justifications—annual presentations to Congress to justify requests for funding—help shed more light on the administration’s priorities for FY 2015.

The results of a Phase III clinical trial for a rotavirus vaccine were released this week and published in The Lancet. The vaccine candidate—which was tested in India—was found to be safe and have modest efficacy of 53.6 percent against severe rotavirus gastroenteritis.

New data shows that the number of principle investigators with National Institutes of Health (NIH) funding dropped significantly last year—between 500 and 1000 researchers. While NIH funding has been on the decline over the last several years, the most significant drop in researchers was due to last year’s sequestration.

GHTC member Seattle BioMed has a received a $9.8 million grant from the National Institute of Allergy and Infectious Diseases to develop two new vaccines against HIV/AIDS. Seattle BioMed will lead a consortium of academic institutions working together on the project, including Rockefeller University, the University of Washington, Seattle Children’s Hospital, and the Fred Hutchinson Cancer Research Center.

Posted in:
back